psychosis

Psychosis is a condition that affects a person’s mind and causes changes to the way that they think, feel and behave. A person who experiences psychosis may be unable to distinguish between reality and their imagination. People who are experiencing psychosis are sometimes referred to as psychotic. They may have hallucinations (where you see or hear things that are not there) and/or delusions (where you believe things that are untrue).

Our psychosis Blogs

Antipsychotics versus CBT in first episode psychosis: some answers, more questions

No Responses »
Profile photo of Joseph Pierre
Posted by
shutterstock_210297724

Joe Pierre summarises two recently published and widely reported RCTs, which suggest that antipsychotic medication might not offer an advantage over psychotherapy in broadly-defined first episode psychosis.

[read the full story...]

Walk this way: can a health coaching intervention increase physical activity in people with severe mental illness?

No Responses »
Profile photo of Gordon Johnston
Posted by
>,
waqar-khalid-xHrkWhLVM8E-unsplash copy

Gordon Johnston and Michel Syrett prepare for the #HealthSMI event on 24th June by blogging about a recent pilot RCT of a health coaching intervention (Walk This Way) to reduce sedentary behaviour and increase physical activity in people with serious mental illness.

[read the full story...]

First episode psychosis in prison: is our screening effective?

1 Response »
Profile photo of Danny Whiting
Posted by
tom-blackout-LJp0F9Icjlc-unsplash

Danny Whiting explores the issue of screening for first episode psychosis in prison using a retrospective cohort study from Australia.

[read the full story...]

Sex and schizophrenia: what determines sexual interest and confidence?

1 Response »
Profile photo of Beccy White
Posted by
kelly-sikkema-XX2WTbLr3r8-unsplash

In her debut blog, Beccy White summarises a secondary analysis which explored predictors of sexual interest amongst older adults with schizophrenia.

[read the full story...]

Antipsychotics for schizophrenia: do they provide a longer, healthier life?

1 Response »
Profile photo of Paul Heron
Posted by
michal-parzuchowski-7TWRwDjfGew-unsplash

Paul Heron from the Closing the Gap Network writes his debut blog about a 20‐year cohort study of physical morbidity and mortality in relationship to antipsychotic treatment in a huge group of people with schizophrenia in Finland.

[read the full story...]

Psychological resilience to suicidal thoughts and behaviours in people with schizophrenia

No Responses »
Profile photo of Emily Hielscher
Posted by
johan-de-jager-CjI5Zg-qzEo-unsplash

Emily Hielscher reviews a recent qualitative study that examines factors that contribute to psychological resilience to suicidal thoughts and behaviours in people with schizophrenia or psychosis.

[read the full story...]

Flu pandemics, schizophrenia and the immune system: could history repeat itself?

No Responses »
Profile photo of Sameer Jauhar
Posted by
shutterstock_1060908011

Sameer Jauhar summarises a recent narrative review about the risk of schizophrenia linked to the Spanish Influenza Pandemic over 100 years ago. He relates this work to our current pandemic and considers the possibility of a link between COVID-19 and an increased risk of psychosis.

[read the full story...]

Towards a symptom-based diagnosis of psychotic spectrum disorders?

No Responses »
Profile photo of Stefanie Sturm
Posted by
nick-fewings-zF_pTLx_Dkg-unsplash

Stefanie Sturm critically analyses a recent paper that suggests a symptom-based continuum of psychosis explains cognitive and real-world functional deficits better than traditional diagnoses.

[read the full story...]

Cardiovascular risk in severe mental illness: is there a right intervention?

No Responses »
Profile photo of Glasgow MSc Students
Posted by
nick-fewings-ka7REB1AJl4-unsplash

A group of Masters Students from the University of Glasgow Global Mental Health MSc write about the Primrose trial, which looked at the clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk in severe mental illness.

[read the full story...]

Risperidone and aripiprazole: genotype, metabolism and dosage

No Responses »
Profile photo of Dolly Sud
Posted by
CYP2D6 genotyping before starting treatment might be valuable in clinical practice for individualising risperidone and aripiprazole treatment.

Dolly Sud writes her debut elf blog on a recent retrospective analysis, which compares dose changes of risperidone and aripiprazole with patients’ individual genotype.

[read the full story...]